Abstract
Objective
This study was aimed at determining the antioxidant, anti-quorum sensing, and in vitro cytotoxic activities of five wild mushroom extracts.
Methods
Wild mushrooms of Auricularia auricula-judae, Termitomyces umkowaani, Trametes elegans, Trametes versicolor, and Microporus xanthopus were collected from Arabuko-Sokoke and Kakamega National Forests, in Kenya. Specimens were identified and extracted using chloroform (CHL), 70% ethanol (Eth), and hot water (HW) solvents. Antioxidant and cytotoxic activities of the extracts were determined using 2,2-diphenyl-1-picrylhydrazyl (DPPH) and Vero cell lines, respectively, while anti-quorum sensing activities were tested against Chromobacterium violaceum. All data were compared using relevant descriptive and inferential statistics at a significance level of p ≤ 0.05.
Results
A total of 35 wild mushrooms were collected, identified, and classified into 14 genera. Among screened mycochemicals, fatty acids, flavonoids, polyphenols, and saponins were detected at higher concentrations. The highest free radical scavenging activities of A. auricula-judae, T. umkowaani, T. elegans, and T. versicolor were observed in 70% Eth extract with the percentage values of 76.40 ± 0.12%, 68.40 ± 0.01%, 62.40 ± 0.07%, and 66.40 ± 0.04%, respectively, whereas the HW extract of Microporus xanthopus showed free radical scavenging activity at 65.90 ± 0.02%. None of the extracts, at the tested concentrations (up to 1000 µg/mL), had shown cytotoxic activity against the Vero cell line. The HW extract of T. umkowaani and the 70% Eth extract of T. versicolor showed a statistically significant difference in the inhibitory activity of violacein production against C. violaceum at the concentration of 200 µg/mL.
Conclusions
The antioxidant activity of wild mushrooms can help to tackle the diseases caused by free radicals. The anti-quorum sensing potential of wild mushrooms could also provide future alternatives to conventional drug therapies cost-effectively. Further detailed chemistry of the bioactive compounds and their possible mechanisms of action responsible for the observed antioxidant and anti-quorum sensing activities are needed.
1. Introduction
Mushrooms are primarily underutilized natural resources [1]. Many academics have recently become interested in mushrooms due to their various and distinctive secondary metabolites [2–4]. The possible secondary metabolites of mushrooms have mostly remained unexplored up to this point. Some secondary metabolites, such as carotenoids, anthraquinones, quinolones, oxalic acid, proteins, peptides, phenolics, polyketides, steroids, anthocyanidins, phytoestrogens, terpenoids, phytosterols, glucosinolates, and flavonoids, have only recently been isolated from a small number of mushroom species for their potential therapeutic, nutritional, and medicinal values [5–7]. These metabolites have demonstrated a variety of bioactivities, including hepatoprotective, antiaging, antibiofilm, anticancer, anti-HIV, anti-inflammatory, antimicrobial, antioxidant, antiparasitic, anti-quorum sensing, and antitumor properties [8–17].
Microbial cells use the signal transduction pathway known as quorum sensing (QS) to communicate with one another and within their own species. The QS transduction pathway is started once the signaling molecules have accumulated to a certain concentration and begun to bind to a protein detector. Finally, this route activates the genes that control pathogenicity, rotting, and biofilm formation [18–20]. One of the most effective methods to tackle microbial diseases and antibiotic resistance is the production of anti-quorum sensing agents from natural resources (fungi, bacteria, and plants) [21].
Our bodies manufacture dangerous free radicals as a result of the respiration, digestion, and metabolism process [22]. Free radicals can exist as distinct molecular species with unpaired electrons. Examples of these species include reactive oxygen species, reactive nitrogen species, hydroxyl, DPPH, superoxide anion, hydrogen peroxide, nitrite, and peroxynitrite [23]. Free radicals are extremely reactive and unstable substances that can damage DNA and cell membranes, obstruct the activity of key enzymes and energy production, obstruct numerous cellular processes essential for healthy body operation, and interfere with regular cell division [23, 24].
To the best of our knowledge, no research has been conducted on the detection of antioxidant and anti-quorum sensing activities of wild mushroom extracts obtained from Arabuko-Sokoke and Kakamega National Reserved Forests in Kenya. Therefore, the purpose of this work was to ascertain the antioxidant and anti-quorum sensing capabilities of bioactive compounds isolated from five indigenous Kenyan wild mushrooms.
2. Materials and Methods
2.1. Description of the Study Areas
Arabuko-Sokoke and Kakamega National Forests are situated within 3°20′S and 39°55′E and 34°32′0″E and 0°10′15″S, respectively, as shown in Figure 1. Arabuko-Sokoke and Kakamega forests are located in coastal and western Kenya with an average annual rainfall of 900 mm–1,100 mm and 1200–1700 mm, respectively. They are rich in biodiversity and their particular importance gives them a very high conservation value [25].
Figure 1.

Map of the study areas.
2.2. Study Design
An experimental and exploratory cross-sectional design was used. An experimental (to ensure that the right kind of data can provide a clear and effective response to the research questions) and exploratory cross-sectional design (evaluates both the exposures and the outcome in study participants at the same time) was used.
2.3. Sample Collection
During the months of March and April 2018, random collections of wild mushrooms on either tree bark or other substrates (wood, soil, or leaf litter) were made. To prevent breakage and preserve moisture content, specimens were wrapped in aluminum foil and put in an ice box. Molecular and morphological methods were used to identify the specimens, together with the assistance of mycology specialists and relevant literature. Finally, samples were preserved for additional analysis after being dried in an electric drying oven for 480 h at 30°C [26, 27].
2.4. Extraction Process of Mycochemicals
Chloroform (CHL), 70% ethanol (Eth), and hot water (HW) solvents were used for the extraction [28, 29]. 100 g of powdered mushroom was combined with 1 L of distilled HW (heated to 60°C for 2 h), 70% Eth (99.9%, Sigma), and 99.8% CHL (Sigma) separately in an Erlenmeyer flask at 25°C and shaken at 150 rpm for 72 h. Whatman No. 1 filter paper was used to filter the extracts, which were then dried in a rotary evaporator at 50°C after being centrifuged at 3000 rpm for 15 min. For additional studies, the extracts were kept in a −80°C deep freezer, freeze-dried, and then kept in a refrigerator at 4°C in an amber-colored bottle.
2.5. Qualitative Mycochemical Screening Assay
The extracts were subjected to a qualitative mycochemical screening analysis according to standard procedures [4]. Distilled water was used to dissolve all extracts.
A foam test was used to determine the presence of saponins. 5 mL of distilled water and 1 mL of each 10 mg/mL extract were added, and then the mixture was shaken vigorously. The presence of saponins is indicated by foam production. The ferric chloride (FeCl3) test revealed the presence of polyphenols. A solution of 2 mL of distilled water, 3 drops of 10% FeCl3, and 3 drops of potassium ferrocyanide were mixed with 1 mL of each extract at a concentration of 10 mg/mL. Blue or green color formation shows the presence of polyphenols [30].
0.5 g of each mushroom extract was boiled in 10% HCl and filtered. To each 2 mL of filtered extracts, 10% ammonia solution was added. The development of pink color in the aqueous layer is a sign that anthraquinones are present [30].
Terpenoids were detected by combining 5 mL of mushroom extracts with 2 mL of CHL, followed by a drop-by-drop H2SO4 along the tube wall. The presence of terpenoids is shown by the production of brown color at the test tube interface [4].
The tannins were determined by adding 3 mL of 10% FeCl3 to each 3 mL of mushroom extract. The presence of tannins is indicated by the production of blue/black color [30].
Mayer's test method was used to determine the alkaloids. Mayer's reagent (1.36 g of mercuric chloride and 5 g of potassium iodide diluted in 100 mL of distilled water) was used to treat a certain amount of the extracts, which resulted in the production of a cream-colored precipitate [4].
H2SO4 was used to determine flavonoids. A fraction of the extracts were treated with concentrated H2SO4 and the production of orange color was noticed [30].
Fatty acids were detected by placing 0.5 mL of extract onto filter paper. 0.5 mL of extract at 20 mg/mL was placed on a filter paper. The presence of fatty acids is indicated if the stain on the filter paper persists. A 2 mL of the extract at 20 mg/mL was dissolved in diethyl ether and evaporated to dryness. The presence of volatile oil is indicated by a pleasant odor [4].
2.6. Antioxidant Activities of Extracts
The antioxidant properties of A. auricula-judae, M. xanthopus, T. umkowaani, T. elegans, and T. versicolor extracts in CHL, 70% Eth, and HW were evaluated using the stable free radical 2,2-diphenyl-1-picrylhydrazyl (DPPH) method [28, 29]. In brief, 4 mL of 400 M DPPH was dissolved in dimethyl sulfoxide (DMSO).
In a test tube, various extract concentrations (10, 20, 30, 40, 50, 60, and 70 g/mL) were made, and 1.00 mL of 400 M DPPH was added. When stable absorption values were attained, the mixture was rapidly mixed and left at room temperature for 1 hour in a dark area. As negative controls, 1.00 mL of distilled water, 70% Eth, CHL, and DPPH were made without extracts. A 1.00 mL sample solution was placed in a cuvette and the color changed from purple to yellow and optical density of the solution was measured using a visible spectrophotometer at 517 nm. Different concentrations of ascorbic acid (10, 20, 30, 40, 50, 60, and 70 µg/mL) were used as a standard antioxidant (positive control). Free radical scavenging activity (FRS) of each extract was expressed as the percentage inhibition of the free radical by the extracts, and it was calculated by using the following formula:
| (1) |
where AS is the absorbance of the solution (extract + DPPH), AAA is the absorbance of ascorbic acid, and ADPPH is the absorbance of the DPPH solution.
The extract concentration providing 50% inhibition (IC50) was calculated from the graph of RSA percentage against extract concentration [23, 31, 32]. Similar to the antioxidant activty of the extracts calculated above, the standandard antioxidant (ascorbic acid) was calculated as follows:
| (2) |
2.7. In Vitro Cytotoxic Activity on Vero Cell Line
The Vero cell line (P171) was grown in T-75 flasks using minimal media that was supplemented with 10% fetal bovine serum (FBS) and 100 g/mL streptomycin (pH 7.25). For 72 h, the T-75 flasks were incubated at 5% CO2 and 37°C to reach confluence. Confluent cells were extracted by trypsinization after being rinsed with phosphate buffer saline. After the suspension had been prepared (10 L of cell suspension, 80 L of saline, and 10 L of Trypan blue (0.40%) in a test tube), the number of viable cells was counted using an inverted phase-contrast microscope and the Trypan blue exclusion test on a hemocytometer slide. A 96-well plate was seeded with an aliquot of 2.0 104 cells/mL suspension and incubated in 5% CO2 at 37°C for 24 h. Then, in a nutshell, 150 mL of the medium was added to the wells in rows H along with 1,000 g/mL of extracts. From row H to row B, a serial dilution was performed. Row A served as the negative control, and the plates were incubated for 48 h at 37°C with 5% CO2. Cell viability was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) test. The capacity of the living cells to convert the yellow MTT dye into a purple formazan product served as a measure of the cells' growth. 10 L of the MTT dye was added to the cells after 48 h, and they were then incubated for 4 h at 37°C with 5% CO2. After removing the entire media from the plates, formazan crystals formed by live cells were dissolved by adding 50 L of dimethyl sulfoxide and vigorously shaking the mixture. Using a microplate reader and a reference wavelength of 720 nm, the absorbance of each well was measured. The following formula was used to calculate cell viability percentage:
| (3) |
where A is the optical density of the control and B is the optical density of extracts. Finally, results were expressed in inhibitory concentration (IC50) values. If the IC50 is > 90 µg/mL, the extract is classified as noncytotoxic. If the IC50 is between 20 and 89 µg/mL, the extract is classified as moderately cytotoxic. If the IC50 is <20 µg/mL, the extract is classified as cytotoxic [33, 34].
2.8. Qualitative Anti-Quorum Sensing Activities of Extracts
Chromobacterium violaceum (CV026) was cultured in tryptic soy broth (Sigma) with shaking (180 rpm) and incubated at 30°C for 18 h [35]. The overnight culture of CV026 was diluted with sterile distilled water and adjusted to a McFarland standard of 0.5 (1.5 × 108 CFU/ml) using a spectrophotometer. A 100 μL of CV026 and 20 μL of the 100 μg/mL C6HSL (hexanoyl homoserine lactone) solution (dissolved in acidified ethyl acetate) were added onto a 5 ml of 1% warm molten tryptic soy agar. Then, the solution was gently mixed and poured immediately over the surface of a solidified tryptic soy agar plate as an overlay. Wells of 5 mm in diameter were made on each plate after the overlay was solidified. A 10 mg/mL extract was dissolved in DMSO and sterilized using a 0.45 µm filter membrane. Of the 10 mg/mL extract, 20 μL, 10 μL, and 5 μL were serially diluted and filled to each well. Another well was filled with 5 μL of 100 μg/mL of C6HSL and 45 μL of sterile tryptic soy broth as a negative control. Finally, assay plates were incubated at 30°C for 72 h [36]. The lack of purple pigment around the bacterium was considered an indication of quorum sensing inhibition (inhibition of violacein production). A clear halo zone without bacterial growth (if any) indicates that the extracts have only antimicrobial activity but not anti-quorum sensing activity.
2.9. Quantitative Anti-Quorum Sensing Activities of Extracts
C. violaceum (20 µL) was inoculated into four Erlenmeyer flasks containing 100 mL lauryl blue (LB) broth and incubated at 30°C for 18 h. The flasks were supplemented with 100 µL of 100 μg/mL C6HSL and 20 µL, 10 µL, and 5 µL of extracts from a stock solution (10 mg/mL). The flasks were incubated again at 30°C with shaking (150 rpm) for 20 h. A 1.00 mL of culture was taken from each flask to the test tube and centrifuged at 8,000 rpm for 10 min to precipitate the insoluble violacein. The supernatant was discarded, and then 1.00 mL of DMSO was added to the test tube and shaken for 30 seconds to completely solubilize the precipitated violacein. The test tube was centrifuged at 8,000 rpm for 10 min to remove cells. Then, 200 µL of the supernatant was added to a 96-well plate in triplicates, and absorbance was read at 585 nm. The percentage of violacein inhibition is calculated as
| (4) |
Simultaneously, the antibacterial effect of the extracts on the growth of the test bacteria was tested by culturing in the presence and absence of extracts and OD was read [37, 38].
2.10. Statistical Analysis
The obtained results of each experiment were performed in triplicates and expressed as the mean ± SD values. Microsoft Excel Package was used to analyze quantitative data and draw graphs. All quantitative data were compared using relevant descriptive and inferential statistics at a significance level of p ≤ 0.05 [9].
3. Results
A total of 35 wild mushrooms were collected from Arabuko-Sokoke National Forest (ASF) (23 specimens) and Kakamega National Forest (KF) (12 specimens). The collected wild mushrooms were classified into 14 genera, namely, Agaricus, Auricularia, Boletus, Cantharellus, Daedaleopsis, Ganoderma, Lactarius, Leucocoprinus, Microporus, Pleurotus, Polyporus, Russula, Termitomyces, and Trametes. These genera were also classified into edible and inedible mushrooms. The edible mushrooms include Agaricus, Auricularia, Cantharellus, Ganoderma, Leucocoprinus, Pleurotus, Termitomyces, and Trametes. The inedible mushrooms are Daedaleopsis, Microporus, and Lactarius. The wild mushrooms which include both edible and inedible categories are Boletus, Polyporus, and Russula.
3.1. Mycochemical Screening
The extracts of the 23 wild mushrooms were qualitatively tested. Alkaloids, anthraquinones, fatty acids, flavonoids, polyphenols, saponins, tannins, terpenoids, and volatile oils were found in various amounts as shown in Table 1. Polyphenol concentrations were highest in Polyporus (ASF1) 70% Eth extract, Trametes (ASF3) HW and 70% Eth extracts, and Termitomyces (ASF14) HW extract. HW, 70% Eth, and CHL extracts of Termitomyces (ASF14) yielded moderate quantities of saponins, terpenoids, and fatty acids. Fatty acids and volatile oils were lacking in HW and 70% Eth extracts in all mushroom species.
Table 1.
Qualitatively screened mycochemicals of wild mushrooms collected from the Arabuko-Sokoke National Forest.
| Mushroom species | Code | Mycochemicals screened from three solvents | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HW extract | 70% Eth extract | CHL extract | ||||||||||||||||||||||||||
| Saponins | Polyphenols | Anthraquinones | Terpenoids | Tannins | Alkaloids | Flavonoids | Fatty acid | Volatile oils | Saponins | Polyphenols | Anthraquinones | Terpenoids | Tannins | Alkaloids | Flavonoids | Fatty acid | Volatile oils | Saponins | Polyphenols | Anthraquinones | Terpenoids | Tannins | Alkaloids | Flavonoids | Fatty acid | Volatile oils | ||
| Polyporus spp. | ASF1 | − | ++ | − | + | + | − | ++ | − | − | − | +++ | + | ++ | − | + | − | − | − | − | ++ | − | + | − | − | +++ | ++ | + |
| Daedaleopsis spp. | ASF2 | + | + | − | + | + | + | + | − | − | + | − | − | + | + | − | + | − | − | − | + | − | − | − | − | − | + | − |
| Trametes spp. | ASF3 | − | +++ | + | − | ++ | − | + | − | − | ++ | +++ | − | + | ++ | − | − | − | − | − | − | − | − | − | − | ++ | − | + |
| Auricularia spp. | ASF4 | ++ | + | − | − | − | − | − | − | − | + | − | − | ++ | − | − | + | − | − | − | − | − | − | − | − | + | + | − |
| Microporous spp. | ASF5 | − | ++ | + | − | − | − | − | − | − | − | − | − | + | − | − | − | − | − | − | + | − | + | − | − | − | − | + |
| Lactarius spp. | ASF6 | + | + | − | − | − | − | + | − | − | + | − | − | + | − | + | − | − | − | − | + | − | + | − | − | − | + | − |
| Russula spp. | ASF7 | − | + | + | + | + | − | − | − | − | − | − | + | − | − | − | + | − | − | − | + | − | − | − | − | − | − | + |
| Ganoderma spp. | ASF8 | + | + | + | + | + | + | + | − | − | + | − | + | + | − | + | − | − | − | + | − | − | − | − | − | − | ++ | + |
| Termitomyces spp. | ASF9 | − | − | − | + | − | + | − | − | − | − | − | − | + | + | − | − | − | − | + | − | − | − | − | − | − | − | + |
| Pleurotus spp. | ASF10 | + | + | + | + | − | − | + | − | − | − | − | − | − | − | + | + | − | − | − | + | − | − | − | − | − | − | − |
| Cantharellus spp. | ASF11 | − | − | − | + | + | − | − | − | − | + | − | + | − | + | + | − | − | − | − | + | − | + | − | − | − | + | − |
| Russula spp. | ASF12 | + | − | − | + | + | + | − | − | − | + | − | − | − | + | − | − | − | − | − | − | − | − | + | − | − | + | + |
| Termitomyces spp. | ASF13 | − | − | − | − | − | + | − | − | − | − | − | + | + | − | − | − | − | − | − | − | − | − | − | − | + | − | + |
| Termitomyces spp. | ASF14 | ++ | +++ | − | − | − | − | − | − | − | + | − | + | ++ | − | − | − | − | − | − | + | − | − | + | − | + | ++ | + |
| Boletus spp. | ASF15 | − | − | − | − | − | − | + | − | − | − | − | − | + | + | − | − | − | − | − | − | − | − | − | − | − | − | − |
| Agaricus spp. | ASF16 | + | + | + | + | + | + | + | − | − | − | − | − | + | − | − | + | − | − | + | − | − | − | + | − | − | + | + |
| Leucocoprinus spp. | ASF17 | − | − | + | + | − | − | + | − | − | − | + | − | − | − | + | + | − | − | + | + | − | − | − | − | − | − | − |
| Termitomyces spp. | ASF18 | − | + | + | − | − | − | − | − | − | − | − | + | − | − | − | − | − | − | − | + | − | + | − | − | − | − | − |
| Termitomyces spp. | ASF19 | − | − | − | − | + | − | − | − | − | + | − | − | − | + | + | − | − | − | − | − | − | − | − | − | + | + | − |
| Agaricus spp. | ASF20 | + | − | − | − | + | + | − | − | − | − | + | + | + | − | − | − | − | − | + | + | − | + | + | − | + | + | − |
| Agaricus spp. | ASF21 | − | − | − | + | − | + | + | − | − | + | − | + | − | − | − | − | − | − | − | + | − | − | − | − | + | − | + |
| Cantharellus spp. | ASF22 | − | − | − | − | + | − | − | − | − | + | + | − | − | + | + | − | − | + | − | + | − | − | + | − | − | + | + |
| Cantharellus spp. | ASF23 | + | + | − | − | − | + | + | − | − | − | ++ | + | − | − | + | − | − | − | + | + | − | − | − | − | − | − | + |
−, absence of mycochemicals; +, presence of less concentrations of mycochemicals; ++, presence of moderate concentrations of mycochemicals; +++, presence of high concentrations of mycochemicals.
Different chemical constituents such as flavonoids, polyphenols, saponins, tannins, and terpenoids, among others, were obtained from all extracts as shown in Table 2.
Table 2.
Qualitatively screened mycochemicals of wild mushrooms collected from Kakamega National Forest.
| Mushroom species | Code | Mycochemicals screened in three solvents | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HW extract | 70% Eth extract | CHL extract | ||||||||||||||||||||||||||
| Saponins | Polyphenols | Anthraquinones | Terpenoids | Tannins | Alkaloids | Flavonoids | Fatty acid | Volatile oils | Saponins | Polyphenols | Anthraquinones | Terpenoids | Tannins | Alkaloids | Flavonoids | Fatty acid | Volatile oils | Saponins | Polyphenols | Anthraquinones | Terpenoids | Tannins | Alkaloids | Flavonoids | Fatty acid | Volatile oils | ||
| Termitomyces spp. | KF1 | + | +++ | − | + | ++ | ++ | + | − | − | − | ++ | − | − | + | − | ++ | − | − | − | + | − | + | + | − | ++ | ++ | ++ |
| Termitomyces spp. | KF2 | ++ | +++ | ++ | + | ++ | − | +++ | − | − | + | + | ++ | + | ++ | ++ | ++ | − | − | − | ++ | − | + | − | − | − | +++ | ++ |
| Termitomyces spp. | KF3 | + | ++ | + | − | − | ++ | ++ | − | − | − | ++ | − | ++ | + | ++ | − | − | − | − | − | − | − | − | − | ++ | ++ | − |
| Termitomyces spp. | KF4 | +++ | − | − | ++ | + | − | − | − | − | − | + | − | + | − | + | + | − | − | − | − | − | − | − | − | + | − | − |
| Auricularia spp. | KF5 | − | − | + | + | − | − | − | − | − | − | − | − | + | + | + | − | − | − | − | + | − | + | − | − | − | − | + |
| Auricularia spp. | KF6 | ++ | +++ | ++ | − | + | + | ++ | − | − | ++ | +++ | − | ++ | + | ++ | − | − | − | + | + | − | + | − | − | + | ++ | + |
| Auricularia spp. | KF7 | − | ++ | − | − | + | − | + | − | − | + | + | + | − | − | − | + | − | − | − | + | − | − | − | − | − | + | + |
| Auricularia spp. | KF8 | +++ | − | − | + | − | + | + | − | − | + | − | − | + | − | − | − | − | − | − | − | − | − | − | − | + | − | − |
| Termitomyces spp. | KF9 | + | − | − | + | − | + | + | − | − | − | ++ | − | + | + | + | + | − | − | + | − | − | − | + | − | − | − | − |
| Trametes spp | KF10 | ++ | +++ | + | + | ++ | − | + | − | − | − | + | − | − | − | + | + | − | − | + | + | − | − | − | − | − | − | − |
| Microporus spp. | KF11 | − | + | − | − | + | − | − | − | − | + | ++ | + | − | + | + | − | − | − | − | + | − | + | − | − | − | − | − |
| Microporus spp. | KF12 | + | ++ | + | ++ | + | − | + | − | − | ++ | + | + | + | − | − | − | − | − | − | + | − | − | ++ | − | ++ | − | ++ |
−, absence of mycochemicals; +, presence of less concentrations of mycochemicals; ++, presence of moderate concentrations of mycochemicals; +++, presence of high concentrations of mycochemicals.
tPolyphenols and flavonoids were found in the highest amounts in the HW extracts of Termitomyces spp. (KF2), whereas saponins, tannins, and anthraquinones were found in moderate concentrations. On the other hand, extracts of Termitomyces spp. (KF2) in 70% Eth included moderate amounts of tannins, alkaloids, flavonoids, and anthraquinones. Moderate fatty acid concentrations were found in the CHL extracts of Termitomyces (KF1), Termitomyces (KF3), and Auricularia (KF6). The majority of the chemicals lacking from the CHL extracts of most mushroom species were present in the HW and 70% Eth extracts of all mushrooms. All mushroom species' CHL extracts lacked alkaloids or anthraquinones. Similarly, none of the mushroom species' HW and 70% Eth extracts contained any fatty acids or volatile oils.
The most prevalent substances in the HW and 70% Eth extracts of the majority of mushroom species were, in general, polyphenols, tannins, flavonoids, and terpenoids. Different amounts of the mycochemical components of the wild mushrooms were discovered, and they declined in polarity from more polar to less polar solvents. Most substances are soluble in HW and solvents containing 70% Eth, with the exception of fatty acids and volatile oils. The polyphenolic concentration of the aqueous and Eth extracts was higher than that of the CHL extracts.
3.2. Determination of Antioxidant Activity of Extracts
3.2.1. FRS Activity of A. auricula-judae
Each extract of A. auricula-judae (KF6) exhibited dose-dependent free radical scavenging (FRS) activity, as shown in Figure 2(a). 70 g/mL was the concentration at which the FRS activity of the extracts in CHL (63.30 ± 0.01%), 70% Eth (76.40 ± 0.12%), and HW (60.90 ± 0.02%) peaked. 40 g/mL, 50 g/mL, and 60 g/mL, respectively, were found to be the inhibitory concentration (IC50) values for 70% Eth, CHL, and HW extracts. The ascorbic acid showed the highest FRS activities despite the fact that all the extracts showed good FRS activities.
Figure 2.

Antioxidant activity of five wild mushroom extracts: (a) A. auricula-judae, (b) M. xanthopus, (c) T. umkowaani, (d) T. elegans, and (e) T. versicolor.
3.2.2. FRS Activity of M. xanthopus
All M. xanthopus (KF12) extracts improved FRS activities as extract concentration rose as shown in Figure 2(b). The HW extract had the highest percentage of FRS activity (65.90 ± 0.02%), followed by the CHL extract (61.30 ± 0.01%) and 70% Eth extract (49.40 ± 0.11%). However, the percentage of FRS activity of ascorbic acid (82.40 ± 0.01%) was determined to be significantly higher than that of all other extracts. The IC50 values of CHL and HW extracts were determined to be between 50 and 60 g/mL.
3.2.3. FRS Activity of T. umkowaani
All T. umkowaani (KF2) extracts contained a significant amount of FRS activity as shown in Figure 2(c). Despite the fact that all extracts demonstrated an encouraging proportion of FRS activities, none of them revealed a higher percentage of FRS activities than ascorbic acid (80.40 ± 0.01%). At 70 g/mL, the 70% Eth extract (63.40 ± 0.01%) had the highest percentage of FRS activity, followed by the HW extract (61.50 ± 0.02%) and the CHL extract (54.30 ± 0.01%). The IC50 values of CHL extract, 70% Eth extract, and HW extract were 60–70 g/mL, 40–50 g/mL, and 50–60 g/mL, respectively.
3.2.4. FRS Activity of T. elegans
The maximal percentage of FRS activity of T. elegans (ASF3) extracts in CHL, 70% Eth, and HW was 49.30 ± 0.03%, 62.40 ± 0.07%, and 55.90 ± 0.01%, respectively. When compared to all mushroom extracts, ascorbic acid (positive control) had the highest FRS activity as shown in Figure 2(d). The IC50 values for 70% Eth and HW extracts were 50 g/mL–60 g/mL and 60 g/mL–70 g/mL, respectively. However, the CHL extract did not reach the IC50 value in the concentrations tested in this study.
3.2.5. FRS Activity of T. versicolor
The percentage of FRS activity of T. versicolor (KF10) extracts rose as the extract concentration increased from 10 g/mL to 70 g/mL Figure 2(e). In comparison to HW (47.90 ± 0.05%) and CHL (43.30 ± 0.02%) extracts, 70% Eth extract demonstrated the highest percentage of FRS activity (66.40 ± 0.04%) at a concentration of 70 g/mL. The IC50 value of 70% Eth was detected at concentrations ranging from 50 g/mL to 60 g/mL; however, the CHL and HW extracts did not achieve the IC50 values at the doses examined in this investigation.
3.3. Cytotoxic Activity of Five Wild Mushroom Extracts
3.3.1. Cytotoxic Activity of A. auricula-judae
Vero cell line cytotoxic activity of A. auricula-judae (KF6) extracts was investigated as shown in Figure 3(a). HW extract (98.86 ± 0.03%) showed the highest level of cell viability, followed by extracts made using CHL (97.12 ± 0.01%) and 70% Eth (87.54 ± 0.02%) at a concentration of 15.625 g/mL. The findings showed that all extracts significantly and dose-dependently inhibited the Vero cell line (p ≤ 0.05). HW, 70% Eth, and CHL extracts all had IC50 values that ranged from 250 to 500 g/mL, 125 to 250 g/mL, and 250 to 500 g/mL, respectively.
Figure 3.

Cytotoxic activity of five wild mushroom extracts: (a) A. auricula-judae, (b) M. xanthopus, (c) T. umkowaani, (d) T. elegans, and (e) T. versicolor.
3.3.2. Cytotoxic Activity of M. xanthopus
The cytotoxic activity of M. xanthopus (KF12) extracts showed no significant effect against the Vero cell line as shown in Figure 3(b). The highest percentage of cell viability in CHL, 70% Eth, and HW extracts was detected in 87.51 ± 0.04%, 96.29 ± 0.05%, and 93.19 ± 0.04%, respectively, at a concentration of 15.625 µg/mL. The IC50 values of CHL, 70% Eth, and HW extracts were observed at 125 µg/mL–250 µg/mL, 62.5 µg/m–125 µg/mL, and 250 µg/mL–500 µg/mL, respectively.
3.3.3. Cytotoxic Activity of T. umkowaani
The extracts of T. umkowaani (KF2) demonstrated a dose-dependent cytotoxic effect on the Vero cell line as shown in Figure 3(c). The maximum percentage of cell viability in CHL extract (82.12 ± 0.02%), 70% Eth extract (96.14 ± 0.04%), and HW extract (88.39 ± 0.01%) was observed at 15.625 µg/mL. The IC50 values of CHL, 70% Eth, and HW extracts were determined at 125 µg/mL–250 µg/mL, 500 µg/mL–1000 µg/mL, and 250 µg/mL–500 µg/mL, respectively.
3.3.4. Cytotoxic Activity of T. elegans
The cytotoxic activity of the three extracts of T. elegans (ASF3) was detected in a very low effect against the Vero cell line as shown in Figure 3(d). The IC50 values of CHL, 70% Eth, and HW extracts showed within the range of 125 µg/mL–250 µg/mL, 500 µg/mL–1000 µg/mL, and 250 µg/mL–500 µg/mL, respectively. The maximum percentage of cell viability at 15.625 µg/mL was observed in HW extract (98.65 ± 0.02%) followed by a CHL extract (91.53 ± 0.03%) and 70% Eth extract (90.68 ± 0.01%). The pattern indicates that as the concentration of the extracts increases, the viability of the cells decreases.
3.3.5. Cytotoxic Activity of T. versicolor
The three T. versicolor (KF10) extracts showed a very minimal cytotoxic effect against the Vero cell line as shown in Figure 3(e). The CHL extract (81.74 ± 0.03%), 70% Eth extract (96.52 ± 0.03%), and HW extract (95.96 ± 0.05%) showed the highest cell viability of the Vero cell at 15.625 µg/mL. The IC50 values of CHL, 70% Eth, and HW extracts were detected at 125 µg/mL–250 µg/mL, 125 µg/mL–250 µg/mL, and 250 µg/mL–500 µg/mL, respectively.
4. Anti-Quorum Sensing Activity of the Mushroom Extracts
4.1. Qualitative Anti-Quorum Sensing Activity of the Extracts
All three extracts screened for anti-QS activity inhibited violacein production in a concentration-dependent pattern as shown in Figure 4. The violacein production was inhibited without any antibacterial effect of the extracts on the growth of the bacterium. This was proven by detecting the presence of the same viable cell counts in the extracts treated group and the control group after subculturing onto agar media.
Figure 4.

Anti-quorum sensing activity of three mushroom extracts.
4.2. Quantification of Violacein Inhibition of Chromobacterium violaceum (CV026)
The HW extract of T. umkowaani (KF2) showed a maximum zone of inhibition (14.00 ± 0.04 mm) against the CV026 at the concentration of 200 µg/mL as shown in Table 3. The halo zone (white zone) around the vicinity of the agar wells was a good indicator of the inhibition of violacein production by the CV026. CHL extract of T. elegans (ASF3) and 70% Eth extract of T. versicolor (KF10), at a concentration of 200 mg/mL, also reduced the production of violacein 11.00 ± 0.05 mm and 11.00 ± 0.01 mm, respectively.
Table 3.
Anti-quorum sensing activity of mushroom extracts.
| Extracts | Concentration (µg/mL) | Zone of QS inhibition (mm) |
|---|---|---|
| CHL extract of T. elegans | 200 | 11.00 ± 0.01 |
| 100 | 9.00 ± 0.02 | |
| 50 | 7.00 ± 0.01 | |
|
| ||
| HW extract of T. umkowaani | 200 | 14.00 ± 0.04 |
| 100 | 13.00 ± 0.06 | |
| 50 | 12.00 ± 0.08 | |
|
| ||
| 70% Eth extract of T. versicolor | 200 | 11.00 ± 0.05 |
| 100 | 9.00 ± 0.03 | |
| 50 | 6.00 ± 0.01 | |
QS, quorum sensing. Values are expressed as mean ± SD.
All three extracts showed anti-QS activity at sub-MIC concentrations as shown in Table 4. The percentage inhibitory effect on the production of violacein was reduced by the CHL extract of T. elegans (75 ± 0.01%), HW extract of T. umkowaani (80 ± 0.02%), and 70% Eth extract of T. versicolor (65 ± 0.03%) at 200 µg/mL. The violacein production was reduced as the concentrations of extracts increased. It was observed that the HW extract of T. umkowaani and the 70% Eth extract of T. versicolor showed a statistically significant difference in the inhibition of violacein production against CV026 (df = 2, F = 11.08, p ≤ 0.05) at 200 µg/mL.
Table 4.
Percentage inhibition of production of violacein in C. violaceum.
| Extracts | Percentage inhibition of production of violacein | ||
|---|---|---|---|
| 200 µg/mL | 100 µg/mL | 50 µg/mL | |
| CHL extract of T. elegans | 75 ± 0.01 | 60 ± 0.02 | 48 ± 0.01 |
| HW extract of T. umkowaani | 80 ± 0.02∗ | 69 ± 0.03 | 56 ± 0.04 |
| 70% Eth extract of T. versicolor | 65 ± 0.03∗ | 54 ± 0.01 | 43 ± 0.02 |
All values are presented as percentages of the results from the control and are expressed as mean ± SD of three independent (triplicate wells) experiments. ∗is expressed as the significant difference among the three mushroom extracts (p < 0.05).
5. Discussion
All of the mushroom extracts in the current investigation had significant FRS activities in doses ranging from 10 g/mL to 70 g/mL. On the other hand, a prior investigation found that the FRS activity of mushroom extracts was 2.11 mg/mL [39]. The existence of numerous different secondary metabolites and differences in the quantity and potency of phenolic compounds are likely to be the primary causes of the inconsistent results of the free radical scavenging activities between the current report and earlier ones [40–42]. Numerous other investigations also claimed that mushroom extracts with high phenolic component concentrations showed excellent FRS actions [43–45].
The results of this study show that the FRS activities among the five mushroom extracts varied widely. In this regard, the IC50 values of the HW extracts of A. auricula-judae, M. xanthopus, T. umkowaani, and T. elegans were observed within the concentration range of 50 g/mL–70 g/mL, with the exception of T. versicolor. In contrast to the results of earlier investigations, the current results' IC50 values were observed at relatively low extract concentrations. For example, many researchers have observed IC50 values of mushroom extracts at 8.68 mg/mL [46], 340 µg/mL [47], and 20.02–0.68 mg/mL [48]. These significant differences could be explained by the presence of reductones, such as ascorbic acid, the number of phenolic compounds, the chemical complexity, and the chemical makeup of the extracts [49]. In addition, different species may have different amounts of the antioxidant components [49, 50].
The most active FRS was found in the T. versicolor 70% Eth extract. This may be because the extract in question contains a variety of powerful antioxidant chemicals, which may work in concert to increase the FRS activity. According to one study report, different solvents may have different effects on the quality, strength, and quantity of antioxidant components [51]. The presence of a high concentration of phenolic acids, carotenoids, tocopherols (vitamin E), and ascorbic acids has also been linked to the antioxidant properties of mushroom extracts, according to numerous research [52–55].
Significant cytotoxic activity against the Vero cell line was shown by all five mushroom species' extracts. Crude extracts having IC50 values larger than 20 g/mL are regarded as noncytotoxic, according to the American National Cancer Institute (ANCI) recommendations [56]. The IC50 values of all five wild mushroom extracts were found to be within the range of noncytotoxic activity. The inhibitory concentrations (IC50) of the three extracts from each wild mushroom species differed against the Vero cell line. The discrepancies in cytotoxic activity among mushroom extracts may be attributed in part to changes in compound polarity and solubility, bioactive component modes of action, and the presence of various cytotoxic chemicals in each extract [57]. In contrast to our findings, a prior investigation found that water extracts had extremely low cytotoxic activity on Vero cell proliferation [58]. This variation could be attributable to the geographical location and extraction procedures used in the current and earlier investigations. More research is needed, however, to determine the causes for the discrepancies and their mechanisms of action.
The results demonstrate that the CHL and 70% Eth extracts have higher cytotoxic activity than the HW extract. The existence of numerous and similar chemicals inside the extracts could explain why the CHL and 70% Eth extracts performed better. T. versicolor polysaccharides, particularly β-glucans, were found to be the most effective antitumor agents [59]. Water-insoluble and alkali-soluble polysaccharides, on the other hand, were shown to have little or no anticancer activity [60, 61].
The anti-QS activity of the T. umkowaani HW extract, the T. elegans CHL extract, and the T. versicolor 70% Eth extract was qualitatively evaluated against CV026. There are no prior publications to compare this work with, as it is the first to demonstrate the anti-QS efficacy of the mentioned mushroom extracts against CV026.
The anti-QS effect of the extracts may result from their ability to limit the production of acyl-homoserine lactones (AHLs), to degrade AHLs, or to block the actions of the autoinducers, despite the fact that their mode of action has not been thoroughly explored. In addition, the CV026's QS system may be interfered with and the genes involved in the quorum sensing process may be downregulated as a result of the synergistic effects of the bioactive substances found in the extracts. According to earlier research, biological quorum quenchers typically disrupt the bacterial quorum sensing circuits by inhibiting the production, transmission, and reception of AHLs signals as well as their receptors with antagonist molecules that are structurally related to AHLs competitive inhibitors [62, 63].
6. Conclusion
Fatty acids, flavonoids, volatile oils, polyphenols, and saponins, which have potential uses in nutrition and medicine, were found in considerable concentrations among the mycochemicals that underwent qualitative screening. According to the present findings, mushroom extracts could be good candidates for anti-quorum sensing and antioxidant agents. The mushroom extracts demonstrated very little cytotoxic activity against the Vero cell line indicating that the mushrooms are safe for use in future downstream processes for drug development. The synthesis of the pigment violacein in C. violaceum was significantly reduced as a result of the mushroom extracts' anti-quorum sensing abilities. The development of novel alternatives for quorum sensing disruption is attracted by the extracts' ability to quench the quorum sensing activity of the bacterium. Untapped mushrooms' anti-quorum sensing capabilities may add a new dimension to research into the creation of inventive anti-quorum sensing agents that could one day offer cost-effective alternatives to the current pharmacological regimens. The bioactive ingredients that are responsible for the antioxidant and anti-quorum sensing actions need to be identified through additional research. The bioactive substances' precise chemical makeup and any potential mechanisms underlying the observed antioxidant and anti-quorum sensing properties also require a further research.
Acknowledgments
The authors acknowledge Pan African University, Institute for Basic Sciences, Technology and Innovation (AU/003/2018/2019), Africa-ai-Japan Project (AJP/003/2018/2019), and Mekelle University (RF/003/2018/2019) for the financial support.
Abbreviations
- ANCI:
American National Cancer Institute
- ASF:
Arabuko-Sokoke forest
- C6HSL:
Hexanoyl homoserine lactone
- CHL:
Chloroform
- CV:
Chromobacterium violaceum
- DMSO:
Dimethyl sulfoxide
- DPPH:
2,2-Diphenyl-1-picrylhydrazyl
- Eth:
Ethanol
- FBS:
Fetal bovine serum
- Fig:
Figure
- FRS:
Free radical scavenging
- HW:
Hot water
- HCl:
Hydrochloric acid
- IC:
Inhibitory concentration
- KF:
Kakamega forest
- LB:
Lauryl blue
- MIC:
Minimum inhibitory concentration
- MTT:
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
- OD:
Optical density
- QS:
Quorum sensing
- rpm:
Revolution per minute
- SD:
Standard deviation
Data Availability
The data used to support the findings of this study are available from the corresponding author upon request.
Disclosure
The funders did not have any role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
Authors' Contributions
GG, DBS, AN, CB, and AGG were involved in the study conception and design. GG performed the laboratory tests and the data analysis. GG, DBS, AN, CB, and AGG wrote and refined the manuscript. All authors read and approved the final manuscript.
References
- 1.Wasser S. Medicinal mushroom science: current perspectives, advances, evidences, and challenges. Biomedical Journal . 2014;37(6):345–353. doi: 10.4103/2319-4170.138318. [DOI] [PubMed] [Google Scholar]
- 2.Sikandar A., Zhang M., Wang Y., et al. Mycochemical screening and analysis, antioxidant activity, and biochemical composition of fermentation strain Snef1216 (Penicillium chrysogenum) Journal of Analytical Methods in Chemistry . 2020;2020:8. doi: 10.1155/2020/3073906.3073906 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Herawati E., Ramadhan R., Ariyani F., et al. Phytochemical screening and antioxidant activity of wild mushrooms growing in tropical regions. Biodiversitas . 2021;22(11):4716–4721. doi: 10.13057/biodiv/d221102. [DOI] [Google Scholar]
- 4.Wandati T. W., Kenji G. M., Onguso J. M. Phytochemicals in edible wild mushrooms from selected areas in Kenya. Journal of Food Research . 2013;2(3):137–144. doi: 10.5539/jfr.v2n3p137. [DOI] [Google Scholar]
- 5.Chugh R. M., Mittal P., Mp N., et al. Fungal mushrooms: a natural compound with therapeutic applications. Frontiers in Pharmacology . 2022;13:16. doi: 10.3389/fphar.2022.925387.925387 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Wu Y., Choi M.-H., Li J., Yang H., Shin H.-J. Mushroom cosmetics: the present and future. Cosmetics . 2016;3:p. 22. doi: 10.3390/cosmetics3030022. [DOI] [Google Scholar]
- 7.Quang D. N., Hashimoto T., Asakawa Y. Inedible mushrooms: a good source of biologically active substances. The Chemical Record . 2006;6(2):79–99. doi: 10.1002/tcr.20074. [DOI] [PubMed] [Google Scholar]
- 8.Kim J. H., Tam C. C., Chan K. L., et al. Applied sciences antimicrobial efficacy of edible mushroom extracts: assessment of fungal resistance. Applied Sciences . 2022;12:1–15. [Google Scholar]
- 9.Gebreyohannes G., Nyerere A., Bii C., Berhe Sbhatu D. Determination of antimicrobial activity of extracts of indigenous wild mushrooms against pathogenic organisms. Evidence-based Complementary and Alternative Medicine . 2019;2019:7. doi: 10.1155/2019/6212673.6212673 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Elkhateeb W. A., Daba G. M., Thomas P. W., Wen T. Medicinal mushrooms as a new source of natural therapeutic bioactive compounds, Egypt. Pharmaceutical Journal . 2019;18:88–101. doi: 10.4103/epj.epj. [DOI] [Google Scholar]
- 11.Elsayed E. A., El Enshasy H., Wadaan M. A. M., Aziz R. Mushrooms: a potential natural source of anti-inflammatory compounds for medical applications. Mediators of Inflammation . 2014;2014:15. doi: 10.1155/2014/805841.805841 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lindequist U., Niedermeyer T. H. J., Jülich W. D. The pharmacological potential of mushrooms. Evidence-based Complementary and Alternative Medicine . 2005;2(3):285–299. doi: 10.1093/ecam/neh107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Garcia J., Rodrigues F., Castro F., Aires A., Marques G., Saavedra M. J. Antimicrobial, antibiofilm, and antioxidant properties of Boletus edulis and neoboletus luridiformis against multidrug-resistant ESKAPE pathogens. Frontiers in Nutrition . 2021;8:13. doi: 10.3389/fnut.2021.773346.773346 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Tamiris R., Taciana A. S., Mircella M. A., Raimundo F., Maria F. S. T. Cultivation and nutritional studies of an edible mushroom from North Brazil. African Journal of Microbiology Research . 2015;9(30):1814–1822. doi: 10.5897/AJMR2015.7526. [DOI] [Google Scholar]
- 15.Zhou W., Cai B., Shan J., Wang S., Di L. Discovery and current status of evaluation system of bioavailability and related pharmaceutical technologies for traditional Chinese medicines—flos lonicerae Japonicae—fructus forsythiae herb couples as an example. International Journal of Molecular Sciences . 2015;16(12):28812–28840. doi: 10.3390/ijms161226132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Gebreyohannes G., Nyerere A., Bii C., Sbhatu D. B. Investigation of antioxidant and antimicrobial activities of different extracts of Auricularia and Termitomyces species of mushrooms. The Scientific World Journal . 2019;2019:10. doi: 10.1155/2019/7357048.7357048 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Gebreyohannes G., Nyerere A., Bii C., Sbhatu D. B. Challenges of intervention, treatment, and antibiotic resistance of biofilm-forming microorganisms. Heliyon . 2019;5(8) doi: 10.1016/j.heliyon.2019.e02192.e02192 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Salman M. K., Abuqwider J., Mauriello G. Anti-quorum sensing activity of probiotics: the mechanism and role in food and gut health. Microorganisms . 2023;11(3):793–818. doi: 10.3390/microorganisms11030793. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Tamfu A. N., Ceylan O., Cârâc G., Talla E., Dinica R. M. Antibiofilm and anti-quorum sensing potential of cycloartane-type triterpene acids from Cameroonian grassland propolis: phenolic profile and antioxidant activity of crude extract. Molecules . 2022;27(15):4872–4919. doi: 10.3390/molecules27154872. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Tamfu A. N., Ceylan O., Fru G. C., Ozturk M., Duru M. E., Shaheen F. Antibiofilm, antiquorum sensing and antioxidant activity of secondary metabolites from seeds of Annona senegalensis, Persoon. Microbial Pathogenesis . 2020;144:9. doi: 10.1016/j.micpath.2020.104191.104191 [DOI] [PubMed] [Google Scholar]
- 21.Yang D., Hao S., Zhao L., et al. Paeonol attenuates quorum-sensing regulated virulence and biofilm formation in Pseudomonas aeruginosa. Frontiers in Microbiology . 2021;12:16. doi: 10.3389/fmicb.2021.692474.692474 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Martemucci G., Costagliola C., Mariano M., D’andrea L., Napolitano P., D’Alessandro A. G. Free radical properties, source and targets, antioxidant consumption and health. Oxygen . 2022;2:48–78. doi: 10.3390/oxygen2020006. [DOI] [Google Scholar]
- 23.Mwangi R. W., Macharia J. M., Wagara I. N., Bence R. L. The antioxidant potential of different edible and medicinal mushrooms. Biomedicine & Pharmacotherapy . 2022;147:15. doi: 10.1016/j.biopha.2022.112621.112621 [DOI] [PubMed] [Google Scholar]
- 24.Sharifi-Rad M., Anil Kumar N. V., Zucca P., et al. Lifestyle, oxidative stress, and antioxidants: back and forth in the pathophysiology of chronic diseases. Frontiers in Physiology . 2020;11:694–721. doi: 10.3389/fphys.2020.00694. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Ojwang D., Onguso J. M., Harvey J. Genetic diversity of Kenyan native oyster mushroom (Pleurotus) Mycologia . 2014;107:32–38. doi: 10.3852/13-186. [DOI] [PubMed] [Google Scholar]
- 26.Mleczek M., Niedzielski P., Kalač P., et al. Multielemental analysis of 20 mushroom species growing near a heavily trafficked road in Poland. Environmental Science & Pollution Research . 2016;23(16):16280–16295. doi: 10.1007/s11356-016-6760-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Siwulski M., Mleczek M., Rzymski P., et al. Screening the multi-element content of Pleurotus mushroom species using inductively coupled plasma optical emission spectrometer (ICP-oes) Food Analytical Methods . 2017;10(2):487–496. doi: 10.1007/s12161-016-0608-1. [DOI] [Google Scholar]
- 28.Estrela A. B., Abraham W. Fungal metabolites for the control of biofilm infections. Agriculture . 2016;6(3):37–26. doi: 10.3390/agriculture6030037. [DOI] [Google Scholar]
- 29.Rabin N., Zheng Y., Opoku-Temeng C., Du Y., Bonsu E., Sintim H. O. Biofilm formation mechanisms and targets for developing antibiofilm agents. Future Medicinal Chemistry . 2015;7(4):493–512. doi: 10.4155/fmc.15.6. [DOI] [PubMed] [Google Scholar]
- 30.Godlewska K., Pacyga P., Szumny A., Szymczycha-Madeja A., Wełna M., Michalak I. Methods for rapid screening of biologically active compounds present in plant-based extracts. Molecules . 2022;27(20):p. 7094. doi: 10.3390/molecules27207094. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Khatua S., Acharya K. Understanding the medicinal prospects of methanolic extract from a recently explored mushroom of tribal delicacy, Jordan. Journal of Biological Sciences . 2022;15:405–411. doi: 10.54319/jjbs/150309. [DOI] [Google Scholar]
- 32.Hossen S. M. M., Hossain M. S., Yusuf A. T. M., Chaudhary P., Emon N. U., Janmeda P. Profiling of phytochemical and antioxidant activity of wild mushrooms: evidence from the in vitro study and phytoconstituent’ s binding affinity to the human erythrocyte catalase and human glutathione reductase. Food Science and Nutrition . 2022;10(1):88–102. doi: 10.1002/fsn3.2650. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Jamil K., Khattak S. H., Farrukh A., et al. Biogenic synthesis of silver nanoparticles using catharanthus roseus and its cytotoxicity effect on Vero cell lines. Molecules . 2022;27(19):6191–6218. doi: 10.3390/molecules27196191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Teplyakova T. V., Pyankov O. V., Safatov A. S., et al. Water extract of the chaga medicinal mushroom, inonotus obliquus (agaricomycetes), inhibits SARS-CoV-2 replication in Vero E6 and Vero cell culture experiments. International Journal of Medicinal Mushrooms . 2022;24(2):23–30. doi: 10.1615/IntJMedMushrooms.2021042012. [DOI] [PubMed] [Google Scholar]
- 35.Broderick N. A., V Stabb E. A chemical counterpunch: Chromobacterium violaceum ATCC 31532 produces violacein in response to translation-inhibiting antibiotics. mBio . 2020;11:1–14. doi: 10.1128/mBio.00948-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Alves M., Ferreira I., Lourenço I., Costa E., Martins A., Pintado M. Wild mushroom extracts as inhibitors of bacterial biofilm formation. Pathogens . 2014;3:667–679. doi: 10.3390/pathogens3030667. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Yıldız S., Gürgen A., Tabbouche S., Serdar G., Sökmen M., Kılıç A. O. Comparison of quorum sensing inhibition and antimicrobial properties of some commercial and wild mushrooms extracted with supercritical CO2. Celal Bayar Üniversitesi Fen Bilimleri Dergisi . 2019;15(2):193–198. doi: 10.18466/cbayarfbe.514436. [DOI] [Google Scholar]
- 38.Tchatchedre M., Amoussa A. M. O., Atindehou M., et al. Anti-quorum sensing, antibacterial, antioxidant activities, and phytoconstituents analysis of medicinal plants used in Bénin: Acacia macrostachya (Rchb. ex DC.) Journal of Applied Biology & Biotechnology . 2020;8:84–93. doi: 10.7324/JABB.2020.80214. [DOI] [Google Scholar]
- 39.Joshi M., Sagar A. In vitro free radical scavenging activity of a wild edible mushroom, Sparassis crispa (wulf.) Fr., from north western himalayas, India. The Journal of Mycology . 2014;2014:4. doi: 10.1155/2014/748531.748531 [DOI] [Google Scholar]
- 40.Solmaz G., Ozen F., Ekinci Y., Bird P. S., Korachi M. Inhibitory and disruptive effects of Shiitake mushroom (Lentinula edodes) essential oil extract on oral biofilms. Jundishapur Journal of Microbiology . 2013;6(9):1–6. doi: 10.5812/jjm.9058. [DOI] [Google Scholar]
- 41.Ozen T., Darcan C., Aktop O., Turkekul I. Screening of antioxidant, antimicrobial activities and chemical contents of edible mushrooms wildly grown in the black sea region of Turkey. Combinatorial Chemistry & High Throughput Screening . 2011;14(2):72–84. doi: 10.2174/138620711794474079. [DOI] [PubMed] [Google Scholar]
- 42.Elmastas M., Isildak O., Turkekul I., Temur N. Determination of antioxidant activity and antioxidant compounds in wild edible mushrooms. Journal of Food Composition and Analysis . 2007;20(3-4):337–345. doi: 10.1016/j.jfca.2006.07.003. [DOI] [Google Scholar]
- 43.Finimundy T. C., Gambato G., Fontana R., et al. Aqueous extracts of Lentinula edodes and Pleurotus sajor-caju exhibit high antioxidant capability and promising in vitro antitumor activity. Nutrition Research . 2013;33(1):76–84. doi: 10.1016/j.nutres.2012.11.005. [DOI] [PubMed] [Google Scholar]
- 44.Rice-Evans C. A., Miller N. J., Paganga G., Paganga Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biology and Medicine . 1996;20(7):933–956. doi: 10.1103/PhysRevB.91.075109. [DOI] [PubMed] [Google Scholar]
- 45.Ishikawa Y., Morimoto K., Hamasaki T. Flavoglaucin, a metabolite of Eurotium chevalieri, its antioxidation and synergism with tocopherol. Journal of the American Oil Chemists’ Society . 1984;61(12):1864–1868. doi: 10.1007/BF02540819. [DOI] [Google Scholar]
- 46.Wang M., Meng X. Y., Yang R. L., et al. Cordyceps militaris polysaccharides can enhance the immunity and antioxidation activity in immunosuppressed mice. Carbohydrate Polymers . 2012;89(2):461–466. doi: 10.1016/j.carbpol.2012.03.029. [DOI] [PubMed] [Google Scholar]
- 47.Pal J., Ganguly S., Tahsin K. S., Acharya K. In vitro free radical scavenging activity of wild edible mushroom, Pleurotus squarrosulus (Mont.) Singer. Indian Journal of Experimental Biology . 2010;48(12):1210–1218. [PubMed] [Google Scholar]
- 48.Pereira E., Barros L., Martins A., Ferreira I. C. F. R. Towards chemical and nutritional inventory of Portuguese wild edible mushrooms in different habitats. Food Chemistry . 2012;130(2):394–403. doi: 10.1016/j.foodchem.2011.07.057. [DOI] [Google Scholar]
- 49.Menaga D., Rajakumar S., Ayyasamy P. M. Free radical scavenging activity of methanolic extract of Pleurotus Florida mushroom. International Journal of Pharmacy and Pharmaceutical Sciences . 2013;5:601–606. [Google Scholar]
- 50.Jayakumar T., Thomas P. A., Sheu J. R., Geraldine P. In-vitro and in-vivo antioxidant effects of the oyster mushroom Pleurotus ostreatus. Food Research International . 2011;44(4):851–861. doi: 10.1016/j.foodres.2011.03.015. [DOI] [Google Scholar]
- 51.Kanagasabapathy G., Malek S. N. A., Kuppusamy U. R., Vikineswary S. Chemical composition and antioxidant properties of extracts of fresh fruiting bodies of Pleurotus sajor-caju (Fr.) singer. Journal of Agricultural and Food Chemistry . 2011;59(6):2618–2626. doi: 10.1021/jf104133g. [DOI] [PubMed] [Google Scholar]
- 52.Glamočlija J., Sokovic M. Fungi a source with huge potential for mushroom pharmaceuticals. Lek. Sirovine . 2017;37:50–56. doi: 10.5937/leksir1737050G. [DOI] [Google Scholar]
- 53.Karaman M., Stahl M., Vulić J., Vesić M., Čanadanović-Brunet J. Wild-growing lignicolous mushroom species as sources of novel agents with antioxidative and antibacterial potentials. International Journal of Food Sciences & Nutrition . 2014;65(3):311–319. doi: 10.3109/09637486.2013.860584. [DOI] [PubMed] [Google Scholar]
- 54.Reis F. S., Barreira J. C. M., Calhelha R. C., et al. Chemical characterization of the medicinal mushroom Phellinus linteus (Berkeley & Curtis) Teng and contribution of different fractions to its bioactivity. LWT-Food Science and Technology . 2014;58(2):478–485. doi: 10.1016/j.lwt.2014.04.013. [DOI] [Google Scholar]
- 55.Barros L., Dueñas M., Ferreira I. C. F. R., Baptista P., Santos-Buelga C. Phenolic acids determination by HPLC-DAD-ESI/MS in sixteen different Portuguese wild mushrooms species. Food and Chemical Toxicology . 2009;47(6):1076–1079. doi: 10.1016/j.fct.2009.01.039. [DOI] [PubMed] [Google Scholar]
- 56.Ampasavate C., Okonogi S., Anuchapreeda S. Cytotoxicity of extracts from fruit plants against leukemic cell lines. African J. Pharm. Pharmacol . 2010;4:13–21. [Google Scholar]
- 57.Reza A., Choi M., Damte D., et al. Comparative antitumor activity of different solvent fractions from an Auricularia auricula-judae ethanol extract in P388D1 and sarcoma 180 cells. Toxicological Research . 2011;27(2):77–83. doi: 10.5487/TR.2011.27.2.077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Chengo J., Adipo N., Kiboi D., et al. Cancer science & therapy antiproliferative activity of Kenyan Trametes versicolor aqueous extract on selected cancer and normal cell lines. Journal of Cancer Science & Therapy . 2016;8:277–282. doi: 10.4172/1948-5956.1000427. [DOI] [Google Scholar]
- 59.Wasser S. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Applied Microbiology and Biotechnology . 2002;60(3):258–274. doi: 10.1007/s00253-002-1076-7. [DOI] [PubMed] [Google Scholar]
- 60.Reza M., Hossain M. A., Lee S. J., et al. Dichlormethane extract of the jelly ear mushroom Auricularia auricula-judae (higher basidiomycetes) inhibits tumor cell growth in vitro. International Journal of Medicinal Mushrooms . 2014;16(1):37–47. doi: 10.1615/IntJMedMushr.v16.i1.40. [DOI] [PubMed] [Google Scholar]
- 61.Gargano M. L., Van Griensven L. J. L. D., Isikhuemhen O. S., et al. Medicinal mushrooms: valuable biological resources of high exploitation potential. Plant Biosystems-An International Journal Dealing with all Aspects of Plant Biology . 2017;151(3):548–565. doi: 10.1080/11263504.2017.1301590. [DOI] [Google Scholar]
- 62.Jiang Q., Chen J., Yang C., Yin Y., Yao K. Quorum sensing: a prospective therapeutic target for bacterial diseases. BioMed Research International . 2019;2019:15. doi: 10.1155/2019/2015978.2015978 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Sokovic M., Ciric A., Glamoclija J., Nikolic M., Van Griensven L. J. L. D. Agaricus blazei hot water extract shows anti quorum sensing activity in the nosocomial human pathogen pseudomonas aeruginosa. Molecules . 2014;19(4):4189–4199. doi: 10.3390/molecules19044189. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data used to support the findings of this study are available from the corresponding author upon request.
